15 Mar 2010 10:34
| For immediate release | 15 March 2010 |
ALLIANCE PHARMA PLC
("the Company")
Major Interest in Shares
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 15 March 2010 that Nigel Wray purchased, on 12 March 2010, 200,000 ordinary shares of 1p each in the Company.
Mr Wray's resultant shareholding is 24,519,995 ordinary shares, equivalent to 11.04% of the Company's issued share capital.
Mr Wray's ordinary shares are held as follows:
| Nominee | Number of ordinary shares |
|
Pershing Keen Nominees Limited Smith & Williamson Nominees Limited Roy Nominees Limited
|
8,905,407 50,000 15,564,588
|
For further information:
Alliance Pharma plc | + 44 (0) 1249 466966 |
| John Dawson, Chief Executive |
|
| Richard Wright, Finance Director |
|
| www.alliancepharma.co.uk |
|
|
|
|
Buchanan Communications | + 44 (0) 20 7466 5000 |
| Mark Court / Stasa Filiplic / Jennie Spivey |
|
|
|
|
| Numis Securities Limited | + 44 (0) 20 7260 1000 |
| Nominated Adviser: Michael Meade / Brent Nabbs |
|
| Corporate Broking: David Poutney |
|
Alliance Pharma (APH)